Gitlab Inc (GTLB) Stock Price Today
Aura AI Summary
Key Stats
- $7.86BMarket Cap
- -Volume
- TechnologySector
- $51.0452W High
- $19.4252W Low
- -Typical Hold Time
- $6.60BEnterprise Value
- -Div Yield
- -Trading Activity
Track Gitlab Inc (GTLB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Gitlab Inc has traded between a low of $19.42 and a high of $51.04, highlighting its annual price range. Buy and sell Gitlab Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Gitlab Inc
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Most Recent News
Ethereum ETFs see $24M outflow after $824M inflow week, signaling a possible pause, not a trend shift.
Ethereum ETFs experienced a $24.29 million outflow on September 8, 2026, following two weeks of record inflows totaling over $1 billion. Most of the outflow came from Grayscale's funds, which have a history of outflows, while BlackRock's and Fidelity...

Class action lawsuit filed against TruGolf for alleged securities violations and share dilution.
A class action lawsuit has been filed against TruGolf Holdings, Inc. and certain officers for alleged violations of federal securities laws during September 2025 to May 2026. The lawsuit claims TruGolf failed to disclose significant dilution caused b...

Class action lawsuit filed against Replimune for alleged securities law violations over misleading FDA data disclosures.
A class action lawsuit has been filed against Replimune Group, Inc. and some of its officers for allegedly making false statements and failing to disclose critical information about FDA study design concerns and incomplete data submissions during Oct...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.